These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23909911)

  • 41. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.
    Nathan DM; McGee P; Steffes MW; Lachin JM;
    Diabetes; 2014 Jan; 63(1):282-90. PubMed ID: 23990364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.
    Masuda T; Katakami N; Watanabe H; Taya N; Miyashita K; Takahara M; Kato K; Kuroda A; Matsuhisa M; Shimomura I
    J Diabetes; 2024 Feb; 16(2):e13486. PubMed ID: 37853936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway.
    Skrivarhaug T; Bangstad HJ; Stene LC; Sandvik L; Hanssen KF; Joner G
    Pediatr Diabetes; 2006 Oct; 7(5):239-46. PubMed ID: 17054444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
    Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
    Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].
    Molitch ME; Steffes MW; Cleary PA; Nathan DM
    Kidney Int; 1993 Mar; 43(3):668-74. PubMed ID: 8455366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'.
    Esmatjes E; De Alvaro F;
    Diabetes Res Clin Pract; 2002 Jul; 57(1):35-43. PubMed ID: 12007728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients.
    Karlberg C; Falk C; Green A; Sjølie AK; Grauslund J
    Acta Diabetol; 2012 Aug; 49(4):263-8. PubMed ID: 21688016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dynamics of diabetic nephropathy and other complications of type I diabetes mellitus in the period of 1996-2002 (data from 2 Kaunas outpatient polyclinics)].
    Bumblyte IA; Pakalnyte R; Radzeviciene L; Sepetauskiene E; Gaupsiene E; Kavaliauskiene J
    Medicina (Kaunas); 2003; 39 Suppl 1():51-8. PubMed ID: 12761421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study.
    Tryggestad JB; Shah RD; Braffett BH; Bacha F; Gidding SS; Gubitosi-Klug RA; Shah AS; Urbina EM; Levitt Katz LE;
    Pediatr Diabetes; 2020 Sep; 21(6):923-931. PubMed ID: 32501612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes.
    Hägg S; Thorn LM; Putaala J; Liebkind R; Harjutsalo V; Forsblom CM; Gordin D; Tatlisumak T; Groop PH;
    Diabetes Care; 2013 Dec; 36(12):4140-6. PubMed ID: 24101700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
    Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
    Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus.
    Wolf G; Müller N; Mandecka A; Müller UA
    Clin Nephrol; 2007 Aug; 68(2):81-6. PubMed ID: 17722706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of early carotid atherosclerosis progression in young patients with type 1 diabetes mellitus.
    Frost D; Friedl A; Beischer W
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):92-4. PubMed ID: 11928073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.